.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Considerations of Adjuvant Therapy in EGFR+ ES-NSCLC

EP. 1: Clinical Evaluation of ES-NSCLC in Japan

October 20th 2020

EP. 2: Determining Resectability in ES-NSCLC

October 20th 2020

EP. 3: Molecular Testing in Early-Stage NSCLC

October 20th 2020

EP. 4: Testing for EGFR in NSCLC Worldwide

October 20th 2020

EP. 5: Standard of Care for EGFR+ ES-NSCLC

October 20th 2020

EP. 6: Adjuvant Approaches in EGFR+ NSCLC

October 20th 2020

EP. 7: Unprecedented Results from ADAURA

October 20th 2020

EP. 8: Practical Implications of ADAURA in NSCLC

October 20th 2020

EP. 9: Paradigm Shift for Early EGFR+ NSCLC

October 20th 2020